$5.40 -0.33 (-5.76%)
11/27/2009 1:00 PM

Cornerstone Therapeutics Inc. (CRTX)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.

Results 1 - 16 of 16

Recs

0
Member Avatar rexlove (96.29) Submitted: 10/29/2009 6:18:51 PM : Outperform Start Price: $5.55 CRTX Score: -5.78

tiny titan

Recs

0
Member Avatar scoobamang (88.43) Submitted: 10/16/2009 2:04:24 PM : Outperform Start Price: $6.02 CRTX Score: -11.03

Good fundamentals in the pharmaceutical industry.

Recs

0
Member Avatar bobsweet (30.42) Submitted: 10/5/2009 1:36:47 PM : Outperform Start Price: $6.39 CRTX Score: -21.17

give it time....it will be on the upswing very shortly

Recs

0
Member Avatar SmallPimpin (98.28) Submitted: 8/14/2009 5:44:06 PM : Outperform Start Price: $6.59 CRTX Score: -29.43

Mmm...pharmaceuticals...

Recs

0
Member Avatar targetphil (24.71) Submitted: 7/29/2009 10:29:33 PM : Outperform Start Price: $9.84 CRTX Score: -56.52

feelin FOOLISH!

Recs

0
Member Avatar sheltie101 (< 20) Submitted: 7/10/2009 10:42:05 PM : Outperform Start Price: $8.11 CRTX Score: -53.33

Asthma as a health problem is increasing and CRTX has solid offerings for treatment.

Recs

0
Member Avatar DNAJUICE (85.52) Submitted: 7/10/2009 7:06:31 PM : Outperform Start Price: $7.63 CRTX Score: -38.36

Very low debt, good products, and profits.

Recs

0
Member Avatar IstvanMagyar (< 20) Submitted: 6/25/2009 2:13:29 AM : Outperform Start Price: $11.24 CRTX Score: -74.74

This company is on an up ward climb so I am jumping on the wave and see were it will go. It produces several drugs for astma, allergies and pain relief.

Recs

0
Member Avatar NoDoughBro (70.24) Submitted: 6/24/2009 11:18:23 PM : Outperform Start Price: $5.72 CRTX Score: -4.92

God I hate this stock. Why? Because I dumped it months ago thinking it would be a big nothing. Augh!

Recs

4
Member Avatar jegray88 (< 20) Submitted: 10/17/2007 12:16:21 PM : Outperform Start Price: $2.40 CRTX Score: +150.54

Recent gov't approval for a sustained release asthma medication. Young company partnering with older more stabilized companies to work on innovations in medicine.

Recs

1
Member Avatar romad829 (55.38) Submitted: 8/15/2007 8:47:14 PM : Outperform Start Price: $2.46 CRTX Score: +137.00

Will go up post fall season.

Recs

1
Member Avatar spikenailz (21.55) Submitted: 7/26/2007 10:42:05 AM : Outperform Start Price: $2.30 CRTX Score: +157.90

They have had huge success with their asthma meds and they have some new ones in late stages of trials. This company has no where to go but up.

Recs

0
Member Avatar kevinnail (37.90) Submitted: 7/26/2007 9:41:58 AM : Outperform Start Price: $2.31 CRTX Score: +156.77

They have some awesome asthma meds on the market and other stuff in the pipeline coming on board in the near future.

Recs

0
Member Avatar jupamc (< 20) Submitted: 6/19/2007 3:30:41 PM : Outperform Start Price: $2.36 CRTX Score: +153.51

Expect major revenue increases starting 2H07 due to increase of effective salesforce from 20 to 240 with Dey partnership and new reformulation of zileuton (ZyFlo CR). May see some earlier rev. uptick due to co-marketing started in Q2. New formulation is a feasible alternative advantage to Singulair, which some people are reporting, produces side effects such as depression, anxiety.

Recs

0
Member Avatar SPECTRAMAN (64.53) Submitted: 6/6/2007 5:48:07 PM : Outperform Start Price: $2.64 CRTX Score: +128.11

Let's see what happens.

Recs

0
Member Avatar henncoop (99.09) Submitted: 5/16/2007 1:27:33 PM : Outperform Start Price: $2.35 CRTX Score: +152.96

new product or reformation of current product should be approved ..so more revenue

Results 1 - 16 of 16

Featured Broker Partners